Cargando…

The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil

OBJECTIVE: To evaluate the impact of COVID-19 pandemic on breast cancer diagnosis in a breast imaging center. METHODS: This was a retrospective cohort study that included women submitted to breast exams and procedures in a private hospital in São Paulo, SP, Brazil, as from the period of most strict...

Descripción completa

Detalles Bibliográficos
Autores principales: Tachibana, Bruna Mayumi Takaki, Ribeiro, Renato Leme de Moura, Federicci, Érica Elisangela Françolin, Feres, Renata, Lupinacci, Felipe Antonio Sulla, Yonekura, Iviny, Racy, Ana Claudia Silveira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687645/
https://www.ncbi.nlm.nih.gov/pubmed/34932776
http://dx.doi.org/10.31744/einstein_journal/2021AO6721
_version_ 1784618215018594304
author Tachibana, Bruna Mayumi Takaki
Ribeiro, Renato Leme de Moura
Federicci, Érica Elisangela Françolin
Feres, Renata
Lupinacci, Felipe Antonio Sulla
Yonekura, Iviny
Racy, Ana Claudia Silveira
author_facet Tachibana, Bruna Mayumi Takaki
Ribeiro, Renato Leme de Moura
Federicci, Érica Elisangela Françolin
Feres, Renata
Lupinacci, Felipe Antonio Sulla
Yonekura, Iviny
Racy, Ana Claudia Silveira
author_sort Tachibana, Bruna Mayumi Takaki
collection PubMed
description OBJECTIVE: To evaluate the impact of COVID-19 pandemic on breast cancer diagnosis in a breast imaging center. METHODS: This was a retrospective cohort study that included women submitted to breast exams and procedures in a private hospital in São Paulo, SP, Brazil, as from the period of most strict social isolation measures, in 2020 (separated in first period of social isolation, March 24 to June 21, 2020, and second period, June 22 to December 31, 2020), as compared to the same period in 2019. The number of exams, cancer detection rates, pathologic findings and risk factors were analyzed. RESULTS: A total of 32,144 patients were included in the study. Breast imaging exams and procedures decreased by 78.9% in the first period, and 2.7% in the second period, in 2020. By the end of 2020, the number of breast cancer lesions detected was just six cases less than in 2019, although the number of patients submitted to mammograms was 35% lower. CONCLUSION: There was a drop in number of breast exams and cancer diagnoses in the first 90 days of the pandemic. The decrease in diagnosis of cancer was partially compensated in the second period, but the number of patients submitted to mammograms by the end of 2020 was lower, still considering a large number of patients with delayed exams.
format Online
Article
Text
id pubmed-8687645
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
record_format MEDLINE/PubMed
spelling pubmed-86876452021-12-24 The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil Tachibana, Bruna Mayumi Takaki Ribeiro, Renato Leme de Moura Federicci, Érica Elisangela Françolin Feres, Renata Lupinacci, Felipe Antonio Sulla Yonekura, Iviny Racy, Ana Claudia Silveira Einstein (Sao Paulo) Original Article OBJECTIVE: To evaluate the impact of COVID-19 pandemic on breast cancer diagnosis in a breast imaging center. METHODS: This was a retrospective cohort study that included women submitted to breast exams and procedures in a private hospital in São Paulo, SP, Brazil, as from the period of most strict social isolation measures, in 2020 (separated in first period of social isolation, March 24 to June 21, 2020, and second period, June 22 to December 31, 2020), as compared to the same period in 2019. The number of exams, cancer detection rates, pathologic findings and risk factors were analyzed. RESULTS: A total of 32,144 patients were included in the study. Breast imaging exams and procedures decreased by 78.9% in the first period, and 2.7% in the second period, in 2020. By the end of 2020, the number of breast cancer lesions detected was just six cases less than in 2019, although the number of patients submitted to mammograms was 35% lower. CONCLUSION: There was a drop in number of breast exams and cancer diagnoses in the first 90 days of the pandemic. The decrease in diagnosis of cancer was partially compensated in the second period, but the number of patients submitted to mammograms by the end of 2020 was lower, still considering a large number of patients with delayed exams. Instituto Israelita de Ensino e Pesquisa Albert Einstein 2021-12-15 /pmc/articles/PMC8687645/ /pubmed/34932776 http://dx.doi.org/10.31744/einstein_journal/2021AO6721 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Tachibana, Bruna Mayumi Takaki
Ribeiro, Renato Leme de Moura
Federicci, Érica Elisangela Françolin
Feres, Renata
Lupinacci, Felipe Antonio Sulla
Yonekura, Iviny
Racy, Ana Claudia Silveira
The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil
title The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil
title_full The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil
title_fullStr The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil
title_full_unstemmed The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil
title_short The delay of breast cancer diagnosis during the COVID-19 pandemic in São Paulo, Brazil
title_sort delay of breast cancer diagnosis during the covid-19 pandemic in são paulo, brazil
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687645/
https://www.ncbi.nlm.nih.gov/pubmed/34932776
http://dx.doi.org/10.31744/einstein_journal/2021AO6721
work_keys_str_mv AT tachibanabrunamayumitakaki thedelayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT ribeirorenatolemedemoura thedelayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT federicciericaelisangelafrancolin thedelayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT feresrenata thedelayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT lupinaccifelipeantoniosulla thedelayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT yonekuraiviny thedelayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT racyanaclaudiasilveira thedelayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT tachibanabrunamayumitakaki delayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT ribeirorenatolemedemoura delayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT federicciericaelisangelafrancolin delayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT feresrenata delayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT lupinaccifelipeantoniosulla delayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT yonekuraiviny delayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil
AT racyanaclaudiasilveira delayofbreastcancerdiagnosisduringthecovid19pandemicinsaopaulobrazil